Coldstream Capital Management Inc Edwards Lifesciences Corp Transaction History

Coldstream Capital Management Inc

$5.98 Billion
Q2 2025

A detailed history of Coldstream Capital Management Inc transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Coldstream Capital Management Inc holds 9,471 shares of EW stock, worth $725,099. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,471

Previous 10,539 10.13%

Holding current value

$725,099

Previous $763,000 3.01%

% of portfolio

0.01%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	SELL	$67.07 - $78.22 $71,630 - $83,538	-1,068 Reduced 10.13%	9,471 $740,000
Q1 2025 May 13, 2025	SELL	$67.95 - $76.19 $20,181 - $22,628	-297 Reduced 2.74%	10,539 $763,000
Q4 2024 Feb 14, 2025	BUY	$64.54 - $75.92 $93,841 - $110,387	1,454 Added 15.5%	10,836 $802,000
Q3 2024 Nov 15, 2024	BUY	$59.7 - $93.78 $72,774 - $114,317	1,219 Added 14.93%	9,382 $619,000
Q2 2024 Aug 07, 2024	BUY	$84.3 - $94.31 $25,458 - $28,481	302 Added 3.84%	8,163 $754,000
Q1 2024 May 13, 2024	BUY	$72.54 - $95.56 $9,937 - $13,091	137 Added 1.77%	7,861 $751,000
Q4 2023 Feb 09, 2024	BUY	$61.71 - $77.76 $88,060 - $110,963	1,427 Added 22.66%	7,724 $588,000
Q3 2023 Nov 02, 2023	SELL	$69.28 - $93.38 $191,628 - $258,289	-2,766 Reduced 30.52%	6,297 $436,000
Q2 2023 Aug 03, 2023	BUY	$81.41 - $94.33 $21,085 - $24,431	259 Added 2.94%	9,063 $854,000
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $127,430 - $145,019	1,716 Added 24.21%	8,804 $728,000
Q4 2022 Jan 10, 2023	BUY	$68.3 - $87.44 $13,728 - $17,575	201 Added 2.92%	7,088 $0
Q2 2022 Aug 08, 2022	SELL	$86.5 - $128.27 $190,992 - $283,220	-2,208 Reduced 38.16%	3,578 $340,000
Q2 2022 Aug 08, 2022	BUY	$86.5 - $128.27 $286,228 - $424,445	3,309 Added 92.48%	6,887 $655,000
Q1 2022 May 11, 2022	SELL	$101.96 - $128.34 $80,752 - $101,645	-792 Reduced 12.04%	5,786 $681,000
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $51,483 - $63,249	484 Added 7.94%	6,578 $852,000
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $288,971 - $344,682	2,808 Added 85.45%	6,094 $486,000
Q2 2021 Aug 16, 2021	BUY	$83.84 - $104.76 $28,589 - $35,723	341 Added 11.58%	3,286 $340,000
Q1 2021 Jun 16, 2021	SELL	$78.68 - $90.67 $12,746 - $14,688	-162 Reduced 5.21%	2,945 $246,000
Q4 2020 Feb 16, 2021	SELL	$71.69 - $91.23 $170,765 - $217,309	-2,382 Reduced 43.4%	3,107 $283,000
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $8,264 - $10,755	123 Added 2.29%	5,489 $438,000
Q2 2020 Aug 12, 2020	BUY	$57.54 - $76.95 $207,719 - $277,789	3,610 Added 205.58%	5,366 $371,000
Q1 2020 May 27, 2020	BUY	$52.41 - $81.0 $366 - $567	7 Added 0.4%	1,756 $331,000
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $3,011 - $3,447	42 Added 2.46%	1,749 $408,000
Q3 2019 Nov 15, 2019	BUY	$61.55 - $75.43 $105,065 - $128,759	1,707 New	1,707 $375,000

Others Institutions Holding EW

# of Institutions

1,448

Shares Held

485M

Call Options Held

2.76M

Put Options Held

1.54M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $47.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.

Account

Coldstream Capital Management Inc Edwards Lifesciences Corp Transaction History